This study was approved by the Memorial Sloan Kettering Cancer Center (MSKCC) Institutional Review Board (IRB). All patient-derived xenografts (PDXs) were generated by the Antitumor Assessment Core at MSKCC (IRB biospecimen protocol #14-091, PI: de Stanchina). Patients informed consent was required and obtained for all cases (IRB# 06-107, IRB#12-245, {"type":"clinical-trial","attrs":{"text":"NCT02954536","term_id":"NCT02954536"}}NCT02954536, IRB# 06-103, {"type":"clinical-trial","attrs":{"text":"NCT01913639","term_id":"NCT01913639"}}NCT01913639, {"type":"clinical-trial","attrs":{"text":"NCT01522768","term_id":"NCT01522768"}}NCT01522768). Animal studies were performed in the MSKCC animal facility in compliance with institutional guidelines under Institutional Animal Care and Use Committee (IACUC) approved protocols (MSKCC No. 08-07-013, PI: Lewis). Human NK cells were obtained from STEMCELL Technologies - Institutional Biosafety Committee # LAB201900146 (PI: Lewis).
Copyright and License information: The Author(s) ©2022 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
Request a Protocol
Ask a
question
Post a Question
